Filling the need for trusted information on national health issues

Private Sector Involvement

  • Your Selections:

Refine Results



GSK, Partners To Begin Pilot Program For Malaria Vaccine In Africa This Month; Sanaria Experimental Malaria Vaccine To Begin Large Trial On African Island In 2020

Bloomberg: Malaria Vaccine Took 30 Years. It’s Still a Work in Progress “After more than three decades of work and almost $1 billion of investment, GlaxoSmithKline Plc and its partners are ready to deploy a vaccine for malaria, the mosquito-borne disease that kills almost half a million people each year.…

More News In Global Health

Agence France-Presse: Push to cure hepatitis B, a neglected disease (4/10). Al Jazeera: Death toll from devastating Cyclone Idai rises above 1,000 (4/10). Borgen Magazine: How Drug Manufacturers are Treating Neglected Tropical Diseases (Sharek, 4/10). Malay Mail: Rights advocates worry conservatism hampering women’s sexual, reproductive health (Zurairi AR, 4/11). NPR:…

Media Outlets Examine Barriers To TB R&D, Access To Treatment

Devex: Will new TB treatments reach those who need them most? “Pharma giant GlaxoSmithKline is pursuing new treatments for tuberculosis but insists it will need support from governments and funding agencies if it is to get them to patients in lower-income countries, the head of its global health unit, David…

USAID Administrator Mark Green Highlights Key Aspects Of FY 2020 Budget Request In Written Testimony For House Foreign Affairs Committee

USAID: Written Statement of USAID Administrator Mark Green before the House Foreign Affairs Committee In written testimony for a hearing in the House Foreign Affairs Committee on USAID’s FY 2020 budget request, USAID Administrator Mark Green discussed key aspects of the request, including the U.S. humanitarian response to Venezuela, Tropical…